AI assistant
Sending…
PIRAMAL PHARMA LIMITED — Capital/Financing Update 2023
Aug 3, 2023
59525_rns_2023-08-03_62fc556a-86b1-4225-95f6-dcfa9540ae8f.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [145 x 60] intentionally omitted <==
A. Statement of utilization of issue proceeds:
| Name of theIssuer | ISIN | Mode of FundRaising(Publicissues/Privateplacement) | Type ofinstrument | Date ofraisingfunds | AmountRaised(Rs. incrores) | Fundsutilized(Rs. incrores) | Anydeviation(Yes / No) | If 8 is Yes,then specifythe purposeof for whichthe fundswere utilized | Remarks,if any |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| Piramal PharmaLimited | INE0DK507034 | PrivatePlacement | Non-ConvertibleDebentures | 03.10.2022 | 100 | 100 | No | - | - |
| Total | 100 | 100 |
Piramal Pharma Limited
CIN: U24297MH2020PLC338592
Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000
piramal.com
==> picture [145 x 60] intentionally omitted <==
B. Statement of deviation / variation in utilization of funds raised
| Particulars | Remarks | Remarks | Remarks | Remarks | Remarks | Remarks |
|---|---|---|---|---|---|---|
| Name of listed entity | Piramal Pharma Limited | |||||
| Mode of fund raising | Private Placement | |||||
| Type of instrument | Non-ConvertibleDebentures | |||||
| Date of raising funds | As mentioned above in point no. A | |||||
| Amount raised (Rs. in crores) | ||||||
| Report filed for quarter ended | 30.06.2023 | |||||
| Is there a deviation / variation in use of funds raised? | No | |||||
| Whether any approval is required to vary the objects ofthe issue stated in the prospectus/ offer document? | No | |||||
| If yes, details of the approval so required? | N.A. | |||||
| Date of approval | ||||||
| Explanation for the deviation / variation | ||||||
| Comments of the audit committee after review | ||||||
| Comments of the auditors, if any | ||||||
| Objects for which funds have been raised and where there has been a deviation / variation, in the following table | ||||||
| Original object | Modifiedobject, ifany | Originalallocation | Modifiedallocation,if any | Fundsutilized | Amount of deviation/variationfor the quarter according toapplicable object (in Rs.Crore and in %) | Remarks,if any |
| N.A., since there was no deviation in the utilization of funds from the objects stated in the offer documents | ||||||
| Deviation could mean:a) Deviation in the objects or purposes for which the funds have been raised.b) Deviation in the amount of funds actuallyutilized as against what was originallydisclosed. |
Piramal Pharma Limited
CIN: U24297MH2020PLC338592
Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000
piramal.com
More from PIRAMAL PHARMA LIMITED
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 10
Regulatory Filings
2026
May 10
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 29